Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Journal of Dermatological Science|August 30, 2025
Risankizumab differentially modulates circulating T-cell populations in psoriasis according to autoreactivity statusRebecca Favaro, Paola Facheris, Alessandra Formai, et al.
Journal of Autoimmunity|May 26, 2024
Autoreactivity to self-antigens LL37 and ADAMTSL5 influences the clinical response to risankizumab in psoriatic patientsRebecca Favaro, Paola Facheris, Alessandra Formai, et al.
Dermatology and Therapy|March 28, 2026
Real-World Effectiveness and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A 52-Week Retrospective Italian Study Focusing on Head and Neck InvolvementLuigi Gargiulo, Luciano Ibba, Matteo Bianco, et al.
Dermatology and Therapy|July 3, 2026
Comparative Effectiveness and Safety of Baricitinib and Ritlecitinib in Severe Alopecia Areata: A Real-World Monocentric Retrospective StudyFrancesco D'Oria, Sara Di Giulio, Luciano Ibba, et al.
Clinical and Experimental Dermatology|April 2, 2025
Potential Role of Leptin in JAK2 Inhibitor-Associated Weight Gain: A Monocentric Retrospective StudyLuciano Ibba, Luigi Gargiulo, Matteo Bianco, et al.
Acta Dermato-Venereologica|October 1, 2021
Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective StudyRiccardo G Borroni, Piergiorgio Malagoli, Luigi Gargiulo, et al.
Journal of Clinical Medicine|January 28, 2026
Tildrakizumab in Managing Psoriasis with Involvement of Difficult-to-Treat Areas: A Multicenter Real-Life Retrospective StudyRuggero Cascio Ingurgio, Angela Alfano, Elena Matteodo, et al.
The Journal of Dermatological Treatment|February 23, 2026
Toward the definition of moderate psoriasis: an expert opinionAntonio Costanzo, Federico Bardazzi, Martina Burlando, et al.
Cancers|February 25, 2023
Long-Term Sequential Digital Dermoscopy of Low-Risk Patients May Not Improve Early Diagnosis of Melanoma Compared to Periodical Handheld DermoscopyRiccardo G Borroni, Vincenzo Panasiti, Mario Valenti, et al.
Medicina (Kaunas, Lithuania)|April 26, 2025
New and Emerging Biologics and Jak Inhibitors for the Treatment of Prurigo Nodularis: A Narrative ReviewMatteo Bianco, Francesco D'Oria, Costanza Falcidia, et al.
Pageof 8